Cilostazol effectiveness in reducing drug-coated stent restenosis in the superficial femoral artery: The ZERO study.

Cilostazol effectiveness in reducing drug-coated stent restenosis in the superficial femoral artery: The ZERO study.

<h4>Purpose</h4>Drug-eluting stents (DESs) play an important role in endovascular therapy (EVT) for femoropopliteal (FP) lesions. Cilostazol improves patency after bare-metal nitinol stent (BNS) implantation for femoropopliteal lesions. This study aimed to establish whether cilostazol is...

Full description

Bibliographic Details
Main Authors: Takashi Miura, Yusuke Miyashita, Koji Hozawa, Tatsuki Doijiri, Tamon Kato, Naoki Hayakawa, Naoto Hashizume, Masatsugu Nakano, Uichi Ikeda, Koichiro Kuwahara, ZERO Investigators
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0270992

Internet

https://doi.org/10.1371/journal.pone.0270992

Similar Items